Pantothenic Acid
Also sold as: Vitamin B5 · D-pantothenic acid · Calcium pantothenate · Pantethine
Vitamin B5 is a precursor of coenzyme A. Nutritional B5, lipid-focused pantethine and topical dexpanthenol have different uses and cannot share one clinical dose target.
Energy
Community
Not enough ratings yet: 0 of 10
Scores appear after 10 ratings, so that one or two reports can't dominate. Tried it? Your rating counts.
Research
- Energy: An older small exercise RCT was null; a role in coenzyme A does not demonstrate extra energy in people without deficiency.
REALITY CHECK // A coenzyme A mechanism does not make B5 an energy booster. The acne evidence is one small sponsored blend trial, while the lipid signal belongs to pantethine. Reports of hair loss, insomnia and agitation at megadoses remain anecdotes rather than established adverse-effect rates.
Levels: how we grade evidence. Grey = evidence of no benefit; amber = evidence it makes this goal worse.
Ratings are self-reported by a self-selected group of users: how it felt, not proof that it works.
Check your bottle
Compare what your label says with what was used in trials. This is a trial range, not a personal prescription.
Enter the amount from your label to see the result.
How it was studied
UPPER LIMIT // No EFSA/IOM upper limit is established in the dossier because toxicity data are insufficient. The adult adequate intake near 5 mg/day is not a safety ceiling. Long-term 5-10 g/day acne megadoses have not been established safe.
Summary
Deficiency is very rare. A single small sponsored acne trial used a roughly 2.2 g/day B5-based blend, not pure B5. Pantethine has separate lipid RCTs; topical panthenol data do not support oral skin claims.
Mechanism
Pantothenate contributes to coenzyme A and acyl-carrier protein, enabling fatty-acid and energy metabolism. Essential biochemical function is not evidence that more substrate improves performance when intake is adequate.
Typical studied dose
The acne RCT used about 2.2 g/day of a pantothenic-acid-based blend for 12 weeks; this is not a verified pure-B5 mass. Pantethine trials used 600-900 mg/day for 16 weeks. Adult adequate intake around 5 mg/day is a nutritional reference, not an acne regimen.
Upper limit
No EFSA/IOM upper limit is established in the dossier because toxicity data are insufficient. The adult adequate intake near 5 mg/day is not a safety ceiling. Long-term 5-10 g/day acne megadoses have not been established safe.
Popular stacks with Pantothenic Acid
Not enough stack data yet. A combination with Pantothenic Acid appears here once 5 people rate the same set.
Forms and label traps
| Form on label | Active content | Studied range / day | Absorption & GI tolerance | Verdict |
|---|---|---|---|---|
| Calcium D-pantothenate, compound mass Best for: Ordinary B5 replacement if needed. |
92% elemental / active | no comparable trial range | Stable standard nutritional salt. Very good at nutritional intakes. |
Studied standard [FORM // REFERENCE] About 92% pantothenic-acid composition by mass; use conversion only when the label actually lists salt mass, not already-declared vitamin B5. The acne blend does not establish a pure-B5 interval. |
| Pantethine Best for: Form-specific lipid evidence. |
Extract weight · marker not quantified | 600–900 mg | Different derivative studied for lipids. Nausea or other GI symptoms can occur at higher doses. |
Good option [FORM // CHECK_BASIS] Compare full pantethine mass with its own trials, without converting into a B5 equivalent. |
| Free D-pantothenic acid Best for: Declared vitamin mass. |
Unstandardized: active content unknown | no comparable trial range | Absorbable, but hygroscopic and less stable than the calcium salt. Generally good at ordinary nutrient intakes. |
Good option [FORM // CHECK_BASIS] No isolated pure-B5 acne dose interval can be inferred from the multi-ingredient blend. Unknown comparator intentionally unavailable. |
Common label traps
- TRAP_01 // 5-10 g B5 reliably clears acne
The sole small sponsored trial used a roughly 2.2 g B5-based blend. It neither isolates B5 nor establishes safety of much larger doses. - TRAP_02 // B5 causes hair loss by washing out biotin
Both use SMVT, but clinically important competition and hair loss in humans are poorly demonstrated. - TRAP_03 // Panthenol creams prove oral B5 hydrates skin
Topical barrier and wound findings cannot be transferred to swallowed B5.
Other outcomes studied
Outside the five leaderboard goals. Same evidence levels as above.
- ACNE Limited · benefit
One sponsored RCT in 41 adults found fewer lesions after 12 weeks with a roughly 2.2 g/day B5-based blend; not proof for isolated B5 or 5-10 g megadoses.
PMID 24831048 - LIPIDS / PANTETHINE Moderate · benefit
Triple-blind placebo/diet-controlled studies at 600-900 mg/day reported about 11% LDL reduction over 16 weeks. This belongs to pantethine and does not replace indicated lipid care.
PMID 24600231 PMID 21925346 - TOPICAL SKIN BARRIER Limited · benefit
Narrative reviews describe topical dexpanthenol barrier, hydration and re-epithelialization findings in heterogeneous small studies; no oral inference.
PMID 28503966 PMID 32610604 PMID 12113650 - DEFICIENCY Limited · benefit
Historical induced-deficiency studies describe burning feet, fatigue and GI symptoms. Isolated deficiency is rare, so this does not justify routine megadoses.
PMID 14361315 PMID 13587673 - RHEUMATOID ARTHRITIS No established evidence
Old observations of altered B5 status do not establish causation or a supplementation treatment benefit. This is unestablished, not a negative treatment RCT.
PMID 14056012 PMID 14404151
Reader questions
Does B5 cause hair loss through biotin competition?
There is a shared transporter, but convincing clinical proof for the hair-loss claim is lacking. Do not diagnose biotin deficiency from an internet mechanism.
What acne dose is both effective and safe?
No reliable isolated-B5 dose is established. The small trial used a blend and does not justify 5-10 g/day. A clinician can help choose evidence-based acne treatment.
Is pantethine the same as a B5 multivitamin?
No. Pantethine lipid studies used hundreds of milligrams, whereas ordinary B5 nutritional intake is around 5 mg/day. These are different compounds and endpoints.
Can I use megadoses indefinitely?
Long-term safety data are insufficient and there is no formal UL. Lack of a UL is not permission to increase indefinitely.
Stack interactions
- Caution Biotin [CAUTION // REVIEW_CONTEXT]
The shared SMVT transporter creates theoretical competition at megadoses; clinical depletion or a proven hair-loss mechanism is not established. - Caution Lipid-lowering or glucose-lowering medicines [CAUTION // REVIEW_CONTEXT]
Pantethine may add to lipid effects; clinical interaction harm is not well documented. Ordinary pantothenic acid has few established drug interactions.
PMID 24600231 - Caution Antibiotics [CAUTION // REVIEW_CONTEXT]
The dossier identifies no documented clinically important B5-antibiotic interaction; absence of evidence is not a reason to invent a spacing protocol.
Red flags: interactions and who should avoid it
Interactions
Biotin: The shared SMVT transporter creates theoretical competition at megadoses; clinical depletion or a proven hair-loss mechanism is not established. Lipid-lowering or glucose-lowering medicines: Pantethine may add to lipid effects; clinical interaction harm is not well documented. Ordinary pantothenic acid has few established drug interactions. Antibiotics: The dossier identifies no documented clinically important B5-antibiotic interaction; absence of evidence is not a reason to invent a spacing protocol.
Avoid or ask a doctor first if
Avoid unsupervised megadoses during pregnancy or lactation; gastrointestinal upset and diarrhea can occur at high doses. Topical panthenol can rarely cause contact allergy. Persistent acne deserves appropriate clinical care.
Sources (PubMed, 15)
- A randomized, double-blind, placebo-controlled study of a novel pantothenic Acid-based dietary supplement in subjects with mild to moderate facial acne.
PMID 24831048 · 2014 · randomized controlled trialSmall sponsored B5-based blend acne RCT.
- Pantethine, a derivative of vitamin B5, favorably alters total, LDL and non-HDL cholesterol in low to moderate cardiovascular risk subjects eligible for statin therapy: a triple-blinded placebo and diet-controlled investigation.
PMID 24600231 · 2014 · randomized controlled trialPantethine 600-900 mg/day lipid findings over 16 weeks.
- Pantethine, a derivative of vitamin B(5) used as a nutritional supplement, favorably alters low-density lipoprotein cholesterol metabolism in low- to moderate-cardiovascular risk North American subjects: a triple-blinded placebo and diet-controlled investigation.
PMID 21925346 · 2011 · randomized controlled trialForm-specific pantethine lipid trial.
- Topical use of dexpanthenol: a 70th anniversary article.
PMID 28503966 · 2017 · narrative reviewTopical dexpanthenol, distinct from oral B5.
- Dexpanthenol in Wound Healing after Medical and Cosmetic Interventions (Postprocedure Wound Healing).
PMID 32610604 · 2020 · narrative reviewPostprocedure topical wound healing review.
- Topical use of dexpanthenol in skin disorders.
PMID 12113650 · 2002 · narrative reviewTopical skin-disorder context.
- Mitochondrial function and toxicity: role of the B vitamin family on mitochondrial energy metabolism.
PMID 16765926 · 2006 · narrative reviewMechanistic B-vitamin mitochondrial role, not energy-boost efficacy.
- B Vitamins and the Brain: Mechanisms, Dose and Efficacy--A Review.
PMID 26828517 · 2016 · narrative reviewB-vitamin mechanisms do not establish benefit in replete users.
- Human pantothenic acid deficiency.
PMID 14361315 · 1955 · historical clinical report / monographHistorical induced human deficiency.
- Pantothenic acid deficiency in man.
PMID 13587673 · 1958 · historical clinical report / monographHistorical experimental deficiency.
- Pantothenic acid. Monograph.
PMID 21951027 · 2011 · historical clinical report / monographPantothenic acid nutritional and formulation context.
- Physiological and performance responses to supplementation with thiamin and pantothenic acid derivatives.
PMID 9650731 · 1998 · randomized controlled trialNull physiological/performance trial of thiamin and pantothenic derivatives.
- THE PANTOTHENIC ACID METABOLISM OF RHEUMATOID ARTHRITIS.
PMID 14056012 · 1963 · historical clinical report / monographHistorical rheumatoid-arthritis status observations, not treatment efficacy.
- Urinary excretion of thiamine, riboflavin, nicotinic acid, and pantothenic acid in patients with rheumatoid arthritis.
PMID 14404151 · 1960 · historical clinical report / monographObservational excretion findings in rheumatoid arthritis.
- Panthenol Allergic Contact Dermatitis: Sources of Exposure, Reported Cases, and a Call for More Frequent Testing.
PMID 39714944 · 2025 · narrative reviewReported topical panthenol contact allergy.
Community comments
No approved comments yet. Comments are held for moderation.